Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm
Objective: To study demographic and clinical features of primary and secondary hemifacial spasm and assess their response to botulinum toxin therapy. Background: Hemifacial spasm (HFS)…Botulinum Neurotoxin (BoNT) for treatment of functional (psychogenic) jerky movement disorders: a randomized placebo-controlled clinical trial
Objective: To assess the effectiveness of botulinum neurotoxin (BonT) in patients with functional jerky movement disorders Background: At least 2–9% of patients seen in movement…Unusual facial synkinesia after Bell’s palsy: interactive Marin-Amat syndrome proven by surface electromyogram, successfully treated with low dose botulinum toxin A.
Objective: To clarify unusal facial synkinesia by using surface electromyogram and botulinum toxin A. Background: Marin-Amat syndrome is a facial synkinesis manifesting as involuntary eyelid…Ultrasonography-guided Botulinum Toxin Type-A Injection in Tremor. An open-label Study
Objective: To assess the role of ultrasound-guided (US) Onabotulinumtoxin-A (BoNT-A) injections for various types of hand and head tremor. Background: Focal treatment of head and…Diaphragmatic myoclonus successfully treated with Botulinum toxin A
Objective: To report a rare case of diaphragmatic myoclonus, which would be the first case successfully treated by injecting Botulinum toxin A (BTX) into the diaphragm under…Long-term effect of botulinum toxin injection in the external oblique muscle to treat camptocormia in three patients with Parkinson’s disease.
Objective: To examine long-term effect of botulinum toxin injection (BTX) in the external oblique muscle (EO) for camptocormia associated with Parkinson’s disease (PD). Background: Camptocormia…Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment
Objective: Case reports. Background: Although botulinum toxin is routinely used as first-line treatment for focal dystonias, little is known about its usefulness in the treatment…Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II
Objective: To evaluate the therapeutic and preventive effect of OnabotulinumtoxinA (BoNT/A) in the treatment of hemifacial spasm, bruxism, and trigeminal neuralgia post Ramsay Hunt Syndrome.…A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery
Objective: To improve our understanding of the pathophysiology and etiology of hemifacial spasm (HFS). Background: HFS is involuntary unilateral contractions of the muscles innervated by…Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe
Objective: To evaluate differences in physicians' understanding of biologic and biosimilar medicines in the USA and Europe. Background: Biologic medicines, such as botulinum toxins and…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- Next Page »